関連する実験動画
Updated: Sep 9, 2025

08:00
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
18.3K
脳腫瘍患者におけるデキサメタゾン:現実世界の医薬品監査
Vindhya Prasad1, Ali Elhag1, Louis Onyiriuka1
1Neurosurgical Department, King's College Hospital NHS Foundation Trust, London, United Kingdom.
Frontiers in neurology
|September 5, 2025
まとめ
脳腫瘍患者のデキサメタゾンの使用は,しばしば明確な離乳計画がないため,合併症のリスクが増加します. 改善された多学科チーム (MDT) のステロイド管理とプロトコルは,より良い患者の結果にとって不可欠です.
科学分野:
- 神経腫瘍学
- 臨床薬理学
- 医療サービス研究
背景:
- デキサメタゾンは 脳腫瘍の腫れに対して 標準的な治療法ですが 実際の応用には 課題があります
- 個々の患者のニーズと複雑なケアシステムは ステロイド管理を複雑にします
研究 の 目的:
- 脳腫瘍患者におけるデキサメタゾンの処方,文書化,および合併症率の評価
- ステロイド関連の合併症に関連する要因を特定し,フォローアップの実践を評価する.
主な方法:
- 316人の脳腫瘍を観察した研究です.
- ステロイドの指示,用量,期間,離乳計画,合併症,およびフォローアップに関するデータ
- 多学科チーム (MDT) の文書と臨床記録の分析
主要な成果:
- 患者の66. 5%がステロイドを投与したが, 断乳計画が文書化されていたのは6%だけだった.
- ステロイド投与開始は手術による管理と関連していた (p<0. 001).
- 長期にわたるステロイド使用とMDTステロイドプランの欠如は合併症を予測した (p<0. 05).
結論:
- 不完全なステロイド計画と長期使用は,有害事象の増加と相関しています.
- 堅固な処方プロトコルと 強化された学際的なフォローアップは不可欠です
- 看護師が指導する診療所は,神経腫瘍学的ケアにおいて効果的なステロイドモニタリングを支援することができます.
関連する概念動画
Pharmacovigilance
981
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
981
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Clinical Trials
7.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.5K
Drug Administration and Therapy Phases: Overview
737
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
737
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K

